Access Limitations Define Americas Weight-Loss Divide More than 22 states now report adult obesity rates above 35%, and in several, including Mississippi, Louisiana, and West Virginia, rates approach or exceed 40%
CITRIC ACID
As things stand now, Medicare cannot directly cover any medications for treating obesity, including newer GLP-1 agents like semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound)
"You can do literally anything like five minutes of walking a day or going to the gym and lifting weights, one is always going to be better than zero no matter what
Wanner C, Schollmeyer P, Hrl WH
dose escalation protocols minimise these effects Injection site reactions : erythema, pruritus, or mild discomfort at subcutaneous injection sites Serious but less common risks include: Pancreatitis : patients should be counselled to seek immediate medical attention if experiencing severe, persistent abdominal pain radiating to the back